[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Kil et al., 2013 - Google Patents

Radiosynthesis of N-(4-chloro-3-[11C] methoxyphenyl)-2-picolinamide ([11C] ML128) as a PET radiotracer for metabotropic glutamate receptor subtype 4 (mGlu4)

Kil et al., 2013

View HTML
Document ID
16849881924320942452
Author
Kil K
Zhang Z
Jokivarsi K
Gong C
Choi J
Kura S
Brownell A
Publication year
Publication venue
Bioorganic & medicinal chemistry

External Links

Snippet

Abstract N-(Chloro-3-methoxyphenyl)-2-picolinamide (3, ML128, VU0361737) is an mGlu 4 positive allosteric modulator (PAM), which is potent and centrally penetrating. 3 is also the first mGlu 4 PAM to show efficacy in a preclinical Parkinson disease model upon systemic …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0453—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/0493—Steroids, e.g. cholesterol, testosterone
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds; Labelled organic compounds per se

Similar Documents

Publication Publication Date Title
Kil et al. Radiosynthesis of N-(4-chloro-3-[11C] methoxyphenyl)-2-picolinamide ([11C] ML128) as a PET radiotracer for metabotropic glutamate receptor subtype 4 (mGlu4)
CN103739605B (en) For detecting the developer of neurological disorder
AU2012304359B2 (en) Compositions, methods, and systems for the synthesis and use of imaging agents
Slavik et al. Discovery of a fluorinated 4‐oxo‐quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2
Fujinaga et al. Synthesis and evaluation of novel radioligands for positron emission tomography imaging of metabotropic glutamate receptor subtype 1 (mGluR1) in rodent brain
Slobbe et al. Development of [18F] afatinib as new TKI-PET tracer for EGFR positive tumors
JP2024056729A (en) Improved synthesis of radiolabeled prostate-specific membrane antigen (PSMA) inhibitor [18F]DCFPyL
Vidal et al. 18 F-F13640 preclinical evaluation in rodent, cat and primate as a 5-HT 1A receptor agonist for PET neuroimaging
Guo et al. Preclinical evaluation of the first adenosine A1 receptor partial agonist radioligand for positron emission tomography imaging
Caballero et al. Synthesis, in silico, in vitro, and in vivo investigation of 5-[11C] methoxy-substituted sunitinib, a tyrosine kinase inhibitor of VEGFR-2
Poot et al. [11C] Sorafenib: Radiosynthesis and preclinical evaluation in tumor-bearing mice of a new TKI-PET tracer
Oi et al. Development of novel PET probes for central 2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl) propionic acid receptors
Haider et al. Synthesis and biological evaluation of thiophene-based cannabinoid receptor type 2 radiotracers for PET imaging
Siméon et al. Synthesis and screening in mice of fluorine-containing PET radioligands for TSPO: discovery of a promising 18F-labeled ligand
Lemoine et al. [18 F] F15599, a novel 5-HT 1A receptor agonist, as a radioligand for PET neuroimaging
Fujinaga et al. Synthesis and evaluation of 6-[1-(2-[18F] fluoro-3-pyridyl)-5-methyl-1H-1, 2, 3-triazol-4-yl] quinoline for positron emission tomography imaging of the metabotropic glutamate receptor type 1 in brain
Vasdev et al. Metabolic stability of 6, 7-dialkoxy-4-(2-, 3-and 4-[18F] fluoroanilino) quinazolines, potential EGFR imaging probes
KR101602912B1 (en) Radiotracer introduced [18F]fluoromethyl group targeting neuroinflammation for PET imaging and Synthesis of Radiotracer and its biological evaluation Method for Radiotracer introduced [18F]fluoromethyl group targeting neuroinflammation for PET imaging
Siméon et al. Synthesis and characterization in monkey of [11 C] SP203 as a radioligand for imaging brain metabotropic glutamate 5 receptors
Kumata et al. Synthesis and evaluation of 4-(2-fluoro-4-[11C] methoxyphenyl)-5-((2-methylpyridin-4-yl) methoxy) picolinamide for PET imaging of the metabotropic glutamate receptor 2 in the rat brain
Malik et al. Development and biological evaluation of [18F] FMN3PA & [18F] FMN3PU for leucine-rich repeat kinase 2 (LRRK2) in vivo PET imaging
Chen et al. Synthesis and evaluation of a 18F-labeled spirocyclic piperidine derivative as promising σ1 receptor imaging agent
Wagner et al. Radiosynthesis and biological evaluation of the new PDE10A radioligand [18F] AQ28A
Chen et al. [18F] BIBD-239: 18F-labeled ER176, a positron emission tomography tracer specific for the translocator protein
Sorger et al. Neuroimaging of the vesicular acetylcholine transporter by a novel 4-[18F] fluoro-benzoyl derivative of 7-hydroxy-6-(4-phenyl-piperidin-1-yl)-octahydro-benzo [1, 4] oxazines